About Varuna Biomedical


We are a team of research, engineering and technology professionals committed to evidence-based exploration of the therapeutic effects of infrared light on living organisms. Our objective is to understand the mechanisms for long-range photo-induced energy transport in biomolecular systems with an eye toward developing novel devices and methods for the treatment and diagnosis of complex disease and disorder.  We seek to better understand the activation pathways by which infrared light stimulates the body’s natural and innate regeneration and protective capacities, and to determine if these pathways can be safely and effectively harnessed for a new generation of biomedical applications.


Varuna is conducting research into vibronic excitation energy transport in biological systems using specially designed opto-mechanical devices in conjunction with ultrafast spectroscopic instrumentation.  We employ multidimensional spectroscopy techniques in controlled experiments to measure and characterize photo-induced resonance energy transport and related molecular dynamics, as well as biological assays to assess metabolic activity in study groups of living organisms.  By exploring the influence of variables such as source wavelength, frequency, fluence, duration and others, we seek to build a clearer and more instructive picture of the mechanisms and opportunities associated with the excitation energy transport and biomodulation phenomenon.


The importance of Varuna’s research program is two-fold.  First, Varuna seeks to further elucidate and expand scientific knowledge and understanding of the role and potential significance of photo-induced energy transport in biological systems.  In doing so we hope to provide new perspectives on the dynamics of both sustained health and disease states.  Secondly, Varuna hopes to uncover new and potentially transformational opportunities for biomedical technology and methods that safely and effectively work in concert with the body’s natural regenerative capacities.  Such modalities hold the promise of enabling both primary and adjuvant applications across multiple disease and disorder categories, together with improved patient quality of life metrics and healthcare economics.